Human Hepatocyte Growth Factor (VM202) Gene Therapy via Transendocardial Injection in a Pig Model of Chronic Myocardial Ischemia-Reference-Cited by-同舟云学术

Human Hepatocyte Growth Factor (VM202) Gene Therapy via Transendocardial Injection in a Pig Model of Chronic Myocardial Ischemia

Published:2011-07 Issue:7 Volume:17 Page:601-611
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Perin Emerson C.,Silva Guilherme V.,Vela Deborah C.,Zheng Yi,Baimbridge Fred,Gahremanpour Amir,Quan Xin,Hahn Woong,Kim Jongmook,Wood Krissy,Kitamura Marina

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Rosamond;Circulation,2008

2. Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies;Stanley;J Cardiovasc Pharmacol Ther,2004

3. Vascular growth factors and angiogenesis in cardiac surgery;Sellke;Ann Thorac Surg,2003

4. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease;Fuchs;Catheter Cardiovasc Interv,2006

5. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One trial;Kastrup;J Am Coll Cardiol,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human placental growth factor-2 in post-infarction left ventricular dysfunction: a randomized, placebo-controlled, preclinical study;Basic Research in Cardiology;2024-08-01

2. Stem cell therapy combined with controlled release of growth factors for the treatment of sphincter dysfunction;Cell & Bioscience;2023-03-16

3. Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor;Clinical and Translational Science;2021-02-02

4. Hepatocyte Growth Factor Regulates the miR-206-HDAC4 Cascade to Control Neurogenic Muscle Atrophy following Surgical Denervation in Mice;Molecular Therapy - Nucleic Acids;2018-09

5. Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model;Experimental & Molecular Medicine;2018-09